3Wolpert S, Bruckman H, Greenlee R, et al. The rt-PA Acute Stroke Study Group.AJNR Am J Neuroradio, 1993,14:3.
4Gregory JZ, Randall TH, Anthony JF, et al. Proc, A Phase ⅡRamdomized Trial of Recombinant Pro-Urokinade by Direct Arterial Delivery in Acute Middle Cerebeal Artery Stroke. Stroke,1998,29:4.
5Boysen G, Overgaard K. Thrombolysis in ischaemic stroke: how far from a clinical breakthrough? J Intern Med, 1995, 37:95.
6Bendszus M, Urbach H, Ries F, et al. Outcome after local intra-arterial fibrinolysis compared with the natural course of patients with a dense middle cerebral artery on early CT.Neuroradiol,1998,40:54.
7Suarez JI, Zaidat OO,Sunshine JI,, et al.Endovascular administration after intravaneous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes.Neurosurgery, 2002, 50(2): 251.
8Reza J,Gary RD.Chelsea SK,et al.lntraarterial Thrombolysis for Treatment of Acute Stroke: Experience in 26 Patients with Long-term Follow-up.AJNR Am J Neuroradiol. 1999,20:1291.
9王拥军.BNC脑血管病临床指南[M].北京:人民卫生出版社,2002.51.
10H. Zeumer,H. -J. Freitag,F. Zanella,A. Thie,C. Arning. Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA)[J] 1993,Neuroradiology(2):159～162
